Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1996 Oct;117(2):327–332. doi: 10.1017/s0950268800001503

The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma.

C Y Tong 1, R Khan 1, N J Beeching 1, W U Tariq 1, C A Hart 1, N Ahmad 1, I A Malik 1
PMCID: PMC2271701  PMID: 8870630

Abstract

To study the occurrence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients with chronic liver disease (CLD) and hepatocellular carcinoma (HCC) in Pakistan, blood samples from 105 sequential patients with biopsy-proven CLD (n = 82) and HCC (n = 23) were tested for HBV and HCV markers. Of the 105, 87 (83%) had evidence of hepatitis B exposure, 58 (55%) were positive for hepatitis B surface antigen (HBsAg), 23 (22%) had hepatitis C antibodies and 25 (24%) had detectable HCV RNA. Significantly more patients with HCC had evidence of HBV exposure in the absence of HCV markers (49/82 vs. 20/23, odds ratio 4.49, 95% CI 1.17-25.16). The proportion of patients positive for HBsAg with no HCV markers was also significantly higher in the HCC group (34/82 vs. 18/23, odds ratio 5.08, 95% CI 1.59-18.96). There were more patients with only HCV markers in the CLD group than the HCC group but the difference was not statistically significant (19/82 vs. 1/23, odds ratio 6.63, 95% CI 0.93-288.01). A modified non-isotopic restriction fragment length polymorphism study on PCR products was used to investigate the epidemiology of HCV genotypes in Pakistan. Due to depletion of the initial samples, a second series of specimens collected one year afterwards was used. Fifteen out of 40 samples had amplifiable product and all were identified as type 3. A commercial serological typing method on the same samples also confirmed that type 3 was the predominant HCV genotype in Pakistan.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blum H. E. Does hepatitis C virus cause hepatocellular carcinoma? Hepatology. 1994 Jan;19(1):251–255. doi: 10.1002/hep.1840190136. [DOI] [PubMed] [Google Scholar]
  2. Bukh J., Miller R. H., Kew M. C., Purcell R. H. Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1848–1851. doi: 10.1073/pnas.90.5.1848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cristiano K., Di Bisceglie A. M., Hoofnagle J. H., Feinstone S. M. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology. 1991 Jul;14(1):51–55. doi: 10.1002/hep.1840140109. [DOI] [PubMed] [Google Scholar]
  4. Cuthbert J. A. Hepatitis C: progress and problems. Clin Microbiol Rev. 1994 Oct;7(4):505–532. doi: 10.1128/cmr.7.4.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dusheiko G., Schmilovitz-Weiss H., Brown D., McOmish F., Yap P. L., Sherlock S., McIntyre N., Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994 Jan;19(1):13–18. [PubMed] [Google Scholar]
  6. Hamasaki K., Nakata K., Tsutsumi T., Tsuruta S., Nakao K., Kato Y., Shima M., Koji T., Nagataki S. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan. J Med Virol. 1993 Jun;40(2):146–149. doi: 10.1002/jmv.1890400212. [DOI] [PubMed] [Google Scholar]
  7. Hanley J. P., Dolan G., Day S., Skidmore S. J., Irving W. L. Interaction of hepatitis B and hepatitis C infection in haemophilia. Br J Haematol. 1993 Nov;85(3):611–612. doi: 10.1111/j.1365-2141.1993.tb03356.x. [DOI] [PubMed] [Google Scholar]
  8. Kew M. C. Hepatitis C virus and hepatocellular carcinoma. FEMS Microbiol Rev. 1994 Jul;14(3):211–219. doi: 10.1111/j.1574-6976.1994.tb00091.x. [DOI] [PubMed] [Google Scholar]
  9. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  10. Lam J. P., McOmish F., Burns S. M., Yap P. L., Mok J. Y., Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis. 1993 Mar;167(3):572–576. doi: 10.1093/infdis/167.3.572. [DOI] [PubMed] [Google Scholar]
  11. Lau J. Y., Mizokami M., Kolberg J. A., Davis G. L., Prescott L. E., Ohno T., Perrillo R. P., Lindsay K. L., Gish R. G., Qian K. P. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis. 1995 Feb;171(2):281–289. doi: 10.1093/infdis/171.2.281. [DOI] [PubMed] [Google Scholar]
  12. Liaw Y. F., Tsai S. L., Chang J. J., Sheen I. S., Chien R. N., Lin D. Y., Chu C. M. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology. 1994 Apr;106(4):1048–1053. doi: 10.1016/0016-5085(94)90766-8. [DOI] [PubMed] [Google Scholar]
  13. Linnen J., Wages J., Jr, Zhang-Keck Z. Y., Fry K. E., Krawczynski K. Z., Alter H., Koonin E., Gallagher M., Alter M., Hadziyannis S. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996 Jan 26;271(5248):505–508. doi: 10.1126/science.271.5248.505. [DOI] [PubMed] [Google Scholar]
  14. Mahaney K., Tedeschi V., Maertens G., Di Bisceglie A. M., Vergalla J., Hoofnagle J. H., Sallie R. Genotypic analysis of hepatitis C virus in American patients. Hepatology. 1994 Dec;20(6):1405–1411. doi: 10.1002/hep.1840200605. [DOI] [PubMed] [Google Scholar]
  15. Majid A., Holmes R., Desselberger U., Simmonds P., McKee T. A. Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J Med Virol. 1995 May;46(1):48–51. doi: 10.1002/jmv.1890460111. [DOI] [PubMed] [Google Scholar]
  16. Malik I. A., Legters L. J., Luqman M., Ahmed A., Qamar M. A., Akhtar K. A., Quraishi M. S., Duncan F., Redfield R. R. The serological markers of hepatitis A and B in healthy population in northern Pakistan. J Pak Med Assoc. 1988 Mar;38(3):69–72. [PubMed] [Google Scholar]
  17. McOmish F., Yap P. L., Dow B. C., Follett E. A., Seed C., Keller A. J., Cobain T. J., Krusius T., Kolho E., Naukkarinen R. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994 Apr;32(4):884–892. doi: 10.1128/jcm.32.4.884-892.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mimms L. T., Mosley J. W., Hollinger F. B., Aach R. D., Stevens C. E., Cunningham M., Vallari D. V., Barbosa L. H., Nemo G. J. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ. 1993 Oct 30;307(6912):1095–1097. doi: 10.1136/bmj.307.6912.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Narendranathan M., Philip M. Reusable needles--a major risk factor for acute virus B hepatitis. Trop Doct. 1993 Apr;23(2):64–66. doi: 10.1177/004947559302300209. [DOI] [PubMed] [Google Scholar]
  20. Okuno H., Xie Z. C., Lu B. Y., Qin X., Takasu M., Kano H., Shiozaki Y., Inoue K. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China. Cancer. 1994 Jan 1;73(1):58–62. doi: 10.1002/1097-0142(19940101)73:1<58::aid-cncr2820730112>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  21. Paterlini P., Gerken G., Nakajima E., Terre S., D'Errico A., Grigioni W., Nalpas B., Franco D., Wands J., Kew M. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med. 1990 Jul 12;323(2):80–85. doi: 10.1056/NEJM199007123230202. [DOI] [PubMed] [Google Scholar]
  22. Pontisso P., Ruvoletto M. G., Fattovich G., Chemello L., Gallorini A., Ruol A., Alberti A. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology. 1993 Nov;105(5):1529–1533. doi: 10.1016/0016-5085(93)90161-5. [DOI] [PubMed] [Google Scholar]
  23. Quraishi M. S., Zuberi S. J., Ahmad M. Hepatitis Bs antigenemia--incidence in apparently healthy adult males. J Pak Med Assoc. 1978 May;28(5):56–57. [PubMed] [Google Scholar]
  24. Sato S., Fujiyama S., Tanaka M., Yamasaki K., Kuramoto I., Kawano S., Sato T., Mizuno K., Nonaka S. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol. 1994 Aug;21(2):159–166. doi: 10.1016/s0168-8278(05)80389-7. [DOI] [PubMed] [Google Scholar]
  25. Simmonds P., Alberti A., Alter H. J., Bonino F., Bradley D. W., Brechot C., Brouwer J. T., Chan S. W., Chayama K., Chen D. S. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994 May;19(5):1321–1324. [PubMed] [Google Scholar]
  26. Simmonds P., Rose K. A., Graham S., Chan S. W., McOmish F., Dow B. C., Follett E. A., Yap P. L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol. 1993 Jun;31(6):1493–1503. doi: 10.1128/jcm.31.6.1493-1503.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Simmonds P. Variability of hepatitis C virus. Hepatology. 1995 Feb;21(2):570–583. doi: 10.1002/hep.1840210243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Takano S., Yokosuka O., Imazeki F., Tagawa M., Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology. 1995 Mar;21(3):650–655. [PubMed] [Google Scholar]
  29. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993 Jun 24;328(25):1797–1801. doi: 10.1056/NEJM199306243282501. [DOI] [PubMed] [Google Scholar]
  30. Valliammai T., Thyagarajan S. P., Zuckerman A. J., Harrison T. J. Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol. 1995 Mar;76(Pt 3):711–716. doi: 10.1099/0022-1317-76-3-711. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES